GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » ROA %

Ibex Technologies (TSXV:IBT) ROA % : 1.14% (As of Jan. 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Ibex Technologies's annualized Net Income for the quarter that ended in Jan. 2024 was C$0.20 Mil. Ibex Technologies's average Total Assets over the quarter that ended in Jan. 2024 was C$17.54 Mil. Therefore, Ibex Technologies's annualized ROA % for the quarter that ended in Jan. 2024 was 1.14%.

The historical rank and industry rank for Ibex Technologies's ROA % or its related term are showing as below:

TSXV:IBT' s ROA % Range Over the Past 10 Years
Min: -14.22   Med: 5.81   Max: 37.33
Current: 25.1

During the past 13 years, Ibex Technologies's highest ROA % was 37.33%. The lowest was -14.22%. And the median was 5.81%.

TSXV:IBT's ROA % is ranked better than
98.32% of 1550 companies
in the Biotechnology industry
Industry Median: -35.055 vs TSXV:IBT: 25.10

Ibex Technologies ROA % Historical Data

The historical data trend for Ibex Technologies's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies ROA % Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.22 11.38 8.16 14.51 26.13

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.99 26.12 57.54 18.68 1.14

Competitive Comparison of Ibex Technologies's ROA %

For the Biotechnology subindustry, Ibex Technologies's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's ROA % distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's ROA % falls into.



Ibex Technologies ROA % Calculation

Ibex Technologies's annualized ROA % for the fiscal year that ended in Jul. 2023 is calculated as:

ROA %=Net Income (A: Jul. 2023 )/( (Total Assets (A: Jul. 2022 )+Total Assets (A: Jul. 2023 ))/ count )
=3.894/( (12.974+16.831)/ 2 )
=3.894/14.9025
=26.13 %

Ibex Technologies's annualized ROA % for the quarter that ended in Jan. 2024 is calculated as:

ROA %=Net Income (Q: Jan. 2024 )/( (Total Assets (Q: Oct. 2023 )+Total Assets (Q: Jan. 2024 ))/ count )
=0.2/( (17.851+17.228)/ 2 )
=0.2/17.5395
=1.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jan. 2024) net income data. ROA % is displayed in the 30-year financial page.


Ibex Technologies  (TSXV:IBT) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jan. 2024 )
=Net Income/Total Assets
=0.2/17.5395
=(Net Income / Revenue)*(Revenue / Total Assets)
=(0.2 / 7.688)*(7.688 / 17.5395)
=Net Margin %*Asset Turnover
=2.6 %*0.4383
=1.14 %

Note: The Net Income data used here is four times the quarterly (Jan. 2024) net income data. The Revenue data used here is four times the quarterly (Jan. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Ibex Technologies ROA % Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines